Bank of New York Mellon Corp Increases Holdings in Fresenius Medical Care Corporation (FMS)

Bank of New York Mellon Corp boosted its holdings in shares of Fresenius Medical Care Corporation (NYSE:FMS) by 3.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 50,834 shares of the company’s stock after acquiring an additional 1,584 shares during the quarter. Bank of New York Mellon Corp’s holdings in Fresenius Medical Care Corporation were worth $2,458,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. SG Americas Securities LLC boosted its position in Fresenius Medical Care Corporation by 205.4% during the 2nd quarter. SG Americas Securities LLC now owns 31,039 shares of the company’s stock worth $1,500,000 after acquiring an additional 20,875 shares during the period. LLBH Private Wealth Management LLC acquired a new stake in Fresenius Medical Care Corporation during the 2nd quarter worth about $230,000. Wrapmanager Inc. boosted its position in Fresenius Medical Care Corporation by 2.4% during the 2nd quarter. Wrapmanager Inc. now owns 7,392 shares of the company’s stock worth $357,000 after acquiring an additional 170 shares during the period. WealthTrust Axiom LLC boosted its position in Fresenius Medical Care Corporation by 17.2% during the 2nd quarter. WealthTrust Axiom LLC now owns 6,124 shares of the company’s stock worth $295,000 after acquiring an additional 898 shares during the period. Finally, Telemus Capital LLC boosted its position in Fresenius Medical Care Corporation by 3.7% during the 2nd quarter. Telemus Capital LLC now owns 7,991 shares of the company’s stock worth $386,000 after acquiring an additional 283 shares during the period. Hedge funds and other institutional investors own 2.61% of the company’s stock.

Shares of Fresenius Medical Care Corporation (FMS) opened at 47.99 on Friday. The firm has a market capitalization of $29.45 billion, a price-to-earnings ratio of 20.60 and a beta of 0.48. Fresenius Medical Care Corporation has a one year low of $38.05 and a one year high of $50.22. The stock’s 50 day moving average price is $48.19 and its 200 day moving average price is $46.76.

Fresenius Medical Care Corporation (NYSE:FMS) last issued its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.05). Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The company had revenue of $4.47 billion for the quarter, compared to analyst estimates of $5.20 billion. During the same period last year, the company posted $0.96 earnings per share. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. Analysts expect that Fresenius Medical Care Corporation will post $2.35 EPS for the current fiscal year.

FMS has been the subject of a number of research reports. Nord/LB restated a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Wednesday, June 28th. BidaskClub lowered Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Royal Bank Of Canada restated a “hold” rating and set a $44.00 price objective on shares of Fresenius Medical Care Corporation in a research report on Wednesday, July 5th. Zacks Investment Research upgraded Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research report on Tuesday, July 11th. Finally, DZ Bank AG restated a “buy” rating on shares of Fresenius Medical Care Corporation in a research report on Monday, August 7th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. Fresenius Medical Care Corporation has a consensus rating of “Hold” and an average target price of $48.33.

TRADEMARK VIOLATION NOTICE: This article was first published by Stock Observer and is the property of of Stock Observer. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://www.thestockobserver.com/2017/10/13/bank-of-new-york-mellon-corp-increases-holdings-in-fresenius-medical-care-corporation-fms.html.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply